{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T18:12:40Z","timestamp":1782929560432,"version":"3.54.5"},"reference-count":16,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T00:00:00Z","timestamp":1549152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T00:00:00Z","timestamp":1549152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1111\/jcpt.12805","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T04:44:01Z","timestamp":1549255441000},"page":"381-383","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A case of simvastatin\u2010induced myopathy with\n            <i>SLCO1B1<\/i>\n            genetic predisposition and co\u2010ingestion of linagliptin and\n            <i>Stevia rebaudiana<\/i>"],"prefix":"10.1155","volume":"44","author":[{"given":"Jones Chun Man","family":"Chan","sequence":"first","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine and Therapeutics, Prince of Wales Hospital The Chinese University of Hong Kong Shatin Hong Kong SAR China"},{"name":"Prince of Wales Hospital Poison Treatment Centre Prince of Wales Hospital, Hospital Authority Shatin Hong Kong SAR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming\u2010Him","family":"Ng","sequence":"additional","affiliation":[{"name":"Prince of Wales Hospital Poison Treatment Centre Prince of Wales Hospital, Hospital Authority Shatin Hong Kong SAR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Siu Ming","family":"Wong","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine and Therapeutics, Prince of Wales Hospital The Chinese University of Hong Kong Shatin Hong Kong SAR China"},{"name":"Prince of Wales Hospital Poison Treatment Centre Prince of Wales Hospital, Hospital Authority Shatin Hong Kong SAR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Department of Medicine and Therapeutics, Prince of Wales Hospital The Chinese University of Hong Kong Shatin Hong Kong SAR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2019,2,3]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv043"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1801-z"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1253\/circj.67.287"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.57"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801936"},{"key":"e_1_2_6_7_1","unstructured":"FDA Drug Safety Communication: Ongoing safety review of high\u2010dose Zocor (simvastatin) and increased risk of muscle injury.2010.https:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm204882.htm. Accessed October 31 2018"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.125"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.09.85"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000176"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.5551\/jat.RV16004"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht055"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.5551\/jat.40204"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.2165\/11630900-000000000-00000"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.5414\/CPP48367"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152510791170960"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2017.09.007"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12805","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcpt.12805","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jcpt.12805","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcpt.12805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:04:09Z","timestamp":1671818649000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,3]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,2,5]]},"published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1111\/jcpt.12805"],"URL":"https:\/\/doi.org\/10.1111\/jcpt.12805","archive":["Portico"],"relation":{},"ISSN":["0269-4727","1365-2710"],"issn-type":[{"value":"0269-4727","type":"print"},{"value":"1365-2710","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,3]]}}}